As the UAE expands its life sciences ambitions, drugmakers are moving into complex generics and biosimilars, boosting healthcare security ... Show more
UAE targets complex generics and biosimilars in pharma manufacturing push
Story Details
| Last Updated | |
| Total Articles | 2 |
Main Topics
develops, produces, and markets drugs or pharmaceuticals licensed for use as medications
News on this topic
UAE targets complex generics and biosimilars in pharma manufacturing push: As the UAE expands its life sciences ambitions, drugmakers are moving into complex ...
khaleejtimes.com/business/uae-targets-complex-generics-and-biosimilars-in-pharma-manufacturing-push
Similar to This
Previous
Biocon expands global reach of Stelara biosimilar to nine more markets: Biocon Expansion: The biosimilar to Johnson & Johnson's Stelara will be commercialised in ...
business-standard.com/companies/news/biocon-yesintek-stelara-biosimilar-market-entry-nine-countries-126102600145_1.html
Biosimilars: Sandoz sets ambitious growth targets: The Basel-based generic drug manufacturer Sandoz has set ambitious growth targets. However ...
nzz.ch/wirtschaft/biosimilars-sandoz-setzt-sich-ehrgeizige-wachstumsziele-ld.10022864
Sandoz expands biosimilars business with Chinese biotech deal: Sandoz has signed a multi-million-dollar agreement with Chinese biotech company Shanghai Henlius ...
swissinfo.ch/eng/pharma-supply-chains/sandoz-expands-biosimilars-business-with-chinese-biotech-deal/91907903
Biocon eyes stronger H2FY27 growth on back of recent US product launches: Biocon expects momentum to strengthen in H2FY27, driven by new US biosimilar and ...
business-standard.com/companies/news/biocon-eyes-stronger-h2fy27-growth-on-back-of-recent-us-product-launches-126080601870_1.html
Sandoz gains on strong biosimilar growth, touts 'golden decade': Swiss generic drug maker Sandoz reported a 9% jump in second-quarter net sales on Wednesday ...
reuters.com/business/healthcare-pharmaceuticals/sandoz-results-narrowly-beat-sales-expectations-2026-08-05/
Lonza, with big Vacaville biotech campus, reports strong first half: The Swiss biomanufacturer Lonza reported a 27% jump in proforma earnings from the first half ...
pressdemocrat.com/2026/07/22/lonza-reports-strong-first-half/
Patent expiries of $300-billion by 2030 offer India a chance to move beyond generics: NITI Aayog
financialexpress.com/business/healthcare/patent-expiries-of-300-billion-by-2030-offer-india-a-chance-to-move-beyond-generics-niti-aayog/4293890/
Drug shortage: Why Germany's discount contracts threaten supply: Cheap drugs on the brink? How the price war in biosimilars and generics is endangering ...
telepolis.de/article/Medikamenten-Mangel-Warum-Deutschlands-Rabattvertraege-die-Versorgung-bedrohen-11357241.html
Indian drugmakers line up for Keytruda biosimilar race as patents near end: Biocon, Zydus, Dr Reddy's are among companies positioning for one of the largest ...
business-standard.com/industry/news/indian-drugmakers-line-up-for-keytruda-biosimilar-race-as-patents-near-end-126062301087_1.html
Paid articlePaywall Indian pharma's next prescription: Specialty drugs, not just generics: Indian drugmakers are reducing reliance on US generics, turning to specialty medicines ...
business-standard.com/industry/news/indian-pharma-s-next-prescription-specialty-drugs-not-just-generics-126061400411_1.html
Paid articlePaywall Biocon Biologics expands pact with Fujifilm – Secures exclusive global right to adalimumab biosimilar, Hulio
financialexpress.com/business/news/biocon-biologics-expands-pact-with-fujifilm-secures-exclusive-global-right-to-adalimumab-biosimilar-hulio/4085799/
WATCH: Health Secretary RFK Jr. announces new FDA move to fast-track biosimilar drug approvals
pbs.org/newshour/politics/watch-live-health-secretary-rfk-jr-announces-new-fda-move-to-fast-track-biosimilar-drug-approvals
Exclusive | Trump Excludes Generics From Big Pharma Tariff Plan: The administration has been weighing duties for months on a range of products and ingredients in ...
wsj.com/health/pharma/trump-generic-prescription-drug-tariffs-3029e024
Paid articlePaywall FDA Approves New Generic Version of the Abortion Pill Mifepristone: The decision, which has drawn backlash from antiabortion groups and lawmakers ...
wsj.com/health/healthcare/fda-abortion-pill-generic-trump-rfk-jr-47a9fa72
Paid articlePaywall
OpinionEasing Malaysia’s NCD economic burden: The case for generics and biosimilars: Letter from Carlos Patarrana, country head, Sandoz Malaysia-Singapore-Brunei
thestar.com.my/opinion/letters/2025/09/26/easing-malaysias-ncd-economic-burden-the-case-for-generics-and-biosimilars
"Generics cost less than cigarettes": Richard Saynor is CEO of the largest European generic drug manufacturer, Sandoz. He speaks to "Presse am Sonntag" about the ...
diepresse.com/20066410/generika-kosten-weniger-als-zigaretten
Lupin inks $50 million licensing deal with Zentiva for global biosimilar rollout: Lupin has signed a $50 million licensing deal with Zentiva for the global ...
financialexpress.com/business/industry-lupin-inks-50-million-licensing-deal-with-zentiva-for-global-biosimilar-rollout-3907804/
Generic Drugmakers Resist New U.S. Manufacturing Despite Trump’s Tariffs: Companies say further domestic investment is too risky in such a low-margin and ...
wsj.com/health/pharma/generic-drugs-us-manufacturing-7381dc47
Paid articlePaywall Trump’s drug pricing order boosts case for generics and biosimilars: Kiran Mazumdar-Shaw
financialexpress.com/business/healthcare/trumps-drug-pricing-order-boosts-case-for-generics-and-biosimilars-kiran-mazumdar-shaw/3843522/
Next